Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis

CompletedOBSERVATIONAL
Enrollment

90,089

Participants

Timeline

Start Date

October 28, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

July 1, 2018

Conditions
Bronchiectasis
Interventions
DRUG

inhaled corticosteroid therapy

We will evaluate and compare the clinical effectiveness and safety of long-term inhaled corticosteroid and macrolide antimicrobial therapies

DRUG

macrolide therapy

We will evaluate and compare the clinical effectiveness and safety of long-term inhaled corticosteroid and macrolide antimicrobial therapies

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

National Jewish Health

OTHER

collaborator

COPD Foundation

OTHER

lead

Oregon Health and Science University

OTHER

NCT02714283 - Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis | Biotech Hunter | Biotech Hunter